CD22 (Clusters of Differentiation 22) inhibitors

Name
CD22 (Clusters of Differentiation 22) inhibitors
Accession Number
DBCAT005742
Description

Not Available

ATC Classification
Drugs
DrugDrug Description
Inotuzumab ozogamicinAn antibody-drug conjugate used to treat B-cell precursor acute lymphoblastic leukemia (ALL).
Moxetumomab pasudotoxA CD22-specific antibody conjugated to a truncated exotoxin used to treat relapsed or refractory hairy cell leukemia in patients who have already been treated with a purine nucleoside analog and one other treatment.
Drugs & Drug Targets
DrugTargetType
Inotuzumab ozogamicinP-glycoprotein 1transporter
Inotuzumab ozogamicinB-cell receptor CD22target
Moxetumomab pasudotoxB-cell receptor CD22target
Moxetumomab pasudotoxElongation factor 2target